Structures by: Karki S.
Total: 20
Theobromine trifluoroacetic acid
C7H8N4O2,C2HF3O2
Organic letters (2007) 9, 16 3133-3136
a=5.09253(14)Å b=8.33537(37)Å c=14.89683(42)Å
α=90.1645(18)° β=95.5873(17)° γ=99.7283(22)°
Theobromine malonic acid
C7H8N4O2,C3H4O4
Organic letters (2007) 9, 16 3133-3136
a=12.44248(60)Å b=12.90355(55)Å c=7.67255(26)Å
α=90° β=91.2464(23)° γ=90°
2
C13H18N4O10
Molecular Pharmaceutics (2007) 4, 3 347
a=17.9217(2)Å b=6.17660(10)Å c=15.3751(3)Å
α=90.00° β=105.2120(10)° γ=90.00°
3
(C8H10N4O2),(C6H8O7)
Molecular Pharmaceutics (2007) 4, 3 347
a=7.38740(10)Å b=8.3967(2)Å c=13.5053(3)Å
α=91.3330(10)° β=99.0400(10)° γ=99.5880(10)°
Nicotinamide:malonic acid 2/1
2(C6H6N2O),C3H4O4
CrystEngComm (2009) 11, 3 470
a=32.9054(6)Å b=4.0078(1)Å c=12.3689(2)Å
α=90.00° β=90.00° γ=90.00°
Nictinamide:fumaric acid 1:1
C6H6N2O,C4H4O4
CrystEngComm (2009) 11, 3 470
a=5.53140(10)Å b=13.7844(4)Å c=14.2056(5)Å
α=90.00° β=92.5900(10)° γ=90.00°
Nicotinamide:glutaric acid 1:1
C6H6N2O,C5H8O4
CrystEngComm (2009) 11, 3 470
a=5.4556(5)Å b=7.3692(6)Å c=15.1945(13)Å
α=99.413(5)° β=94.592(5)° γ=104.775(3)°
Nicotinamide:pimelic acid 1:1
C7H12O4,C6H6N2O
CrystEngComm (2009) 11, 3 470
a=5.4425(1)Å b=7.3981(2)Å c=17.9304(6)Å
α=99.568(2)° β=94.075(2)° γ=104.177(2)°
Nicotinamide:suberic acid 1:1
C6H6N2O,C8H14O4
CrystEngComm (2009) 11, 3 470
a=4.95370(10)Å b=35.2893(6)Å c=8.7180(2)Å
α=90.00° β=94.8320(10)° γ=90.00°
Nicotinamide:azelaic acid 2:1
C6H6N2O,C9H16O4
CrystEngComm (2009) 11, 3 470
a=8.64550(10)Å b=36.5695(6)Å c=5.20210(10)Å
α=90.00° β=90.00° γ=90.00°
Nicotinamide:adipic acid 1:1
C6H10O4,C6H6N2O
CrystEngComm (2009) 11, 3 470
a=5.0110(1)Å b=5.3379(1)Å c=24.0348(6)Å
α=93.036(1)° β=92.753(1)° γ=92.189(1)°
Nicotinamide:adipic acid 2:1
C6H10O4,2(C6H6N2O)
CrystEngComm (2009) 11, 3 470
a=5.0302(3)Å b=5.4600(3)Å c=16.9903(9)Å
α=82.380(4)° β=89.395(4)° γ=90.006(2)°
Nicotinamide:suberic acid 2:1
C8H14O4,2(C6H6N2O)
CrystEngComm (2009) 11, 3 470
a=5.0288(3)Å b=5.4403(3)Å c=18.7537(11)Å
α=93.062(3)° β=94.810(3)° γ=90.740(2)°
Nicotinamide:sebacic acid 2:1
C10H18O4,2(C6H6O2N)
CrystEngComm (2009) 11, 3 470
a=5.0365(2)Å b=5.4470(2)Å c=20.5004(9)Å
α=89.354(2)° β=84.241(2)° γ=89.872(2)°
7105349
Chemical communications (Cambridge, England) (2010) 46, 13 2224-2226
a=5.0907Å b=12.9686Å c=9.2368Å
α=94.0829° β=112.577° γ=104.714°
Theobromine acetic acid
C7H8N4O2,C2H4O2
Chemical communications (Cambridge, England) (2010) 46, 13 2224-2226
a=5.2185(4)Å b=8.2901(8)Å c=12.9358(11)Å
α=95.827(6)° β=96.854(6)° γ=100.333(8)°
Artemisinin-resorcinol 2/1
2(C15H22O5),C6H6O2
CrystEngComm (2010) 12, 12 4038
a=9.5298(2)Å b=17.3699(4)Å c=10.4197(3)Å
α=90.00° β=94.0170(10)° γ=90.00°
Artemisinin-orcinol 1/1
C15H22O5,C7H8O2
CrystEngComm (2010) 12, 12 4038
a=9.0658(1)Å b=14.1061(3)Å c=16.5554(3)Å
α=90.00° β=90.00° γ=90.00°
C28H64Mn4N8
C28H64Mn4N8
Journal of the American Chemical Society (2017) 139, 13 4675-4681
a=34.7647(11)Å b=34.7647(11)Å c=10.8425(4)Å
α=90° β=90° γ=120°
Mn4(NC4H9)7.6105(NMnO3)0.3895
Mn4(NC4H9)7.6105(NMnO3)0.3895
Journal of the American Chemical Society (2017) 139, 13 4675-4681
a=17.2315(15)Å b=12.7392(11)Å c=19.4043(16)Å
α=90° β=90° γ=90°